Regentatlantic Capital LLC Edwards Lifesciences Corp Transaction History
Regentatlantic Capital LLC
- $3.34 Billion
- Q3 2022
A detailed history of Regentatlantic Capital LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Regentatlantic Capital LLC holds 14,226 shares of EW stock, worth $981,451. This represents 0.04% of its overall portfolio holdings.
Number of Shares
14,226
Previous 16,005
11.12%
Holding current value
$981,451
Previous $1.52 Million
22.8%
% of portfolio
0.04%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding EW
# of Institutions
1,352Shares Held
469MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.32 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.52 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.18 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.81 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$933 Million0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $42.7B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...